A Randomized, Open-label, 2×2 Crossover, Phase I Study to Evaluate the Bioequivalence of Single Oral Dose of TAK-536 Pediatric Formulations and TAK-536 Commercial Tablet in Healthy Adult Male Subjects
收藏DataCite Commons2025-10-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007570/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the bioequivalence of a single oral dose of 2
different drug forms of TAK-536 pediatric formulation and a single oral dose of TAK-536
commercial tablet in healthy Japanese adult male participants.
提供机构：
Vivli
创建时间：
2021-12-22
